Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2601 ARTíCULOS , VIENDO DEL 61 AL 75

PUBMED

Motor output variability, deafferentation, and putative deficits in kinesthetic reafference in Parkinson's disease.

Torres EB, Cole J, Poizner H.

Front Hum Neurosci. 2014 Oct 21;8:823. doi: 10.3389/fnhum.2014.00823.

0

0

0

PUBMED

Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson’s disease.

Abbott SK, Li H, Muñoz SS, Knoch B, Batterham M, Murphy KE, Halliday GM, Garner B.

Mov Disord. 2014 Apr;29(4):518-26.

0

0

0

PUBMED

Sigma-1 receptor: a potential new target for Parkinson's disease?

Francardo V.

Neural Regen Res. 2014 Nov 1;9(21):1882-3. doi: 10.4103/1673-5374.145351. No abstract available.

0

0

0

PUBMED

PEP-1-PEA-15 protects against toxin-induced neuronal damage in a mouse model of Parkinson's disease.

Ahn EH, Kim DW, Shin MJ, Kim HR, Kim SM, Woo SJ, Eom SA, Jo HS, Kim DS, Cho SW, Park J, Eum WS, Choi SY.

Biochim Biophys Acta. 2014 Jun;1840(6):1686-700. doi: 10.1016/j.bbagen.2014.01.004.

0

0

0

PUBMED

DYRK1A promotes dopaminergic neuron survival in the developing brain and in a mouse model of Parkinson's disease.

Barallobre MJ, Perier C, Bové J, Laguna A, Delabar JM, Vila M, Arbonés ML.

Cell Death Dis. 2014 Jun 12;5:e1289. doi: 10.1038/cddis.2014.253.

0

0

0

PUBMED

New treatments for the motor symptoms of Parkinson's disease.

Vijverman AC, Fox SH.

Expert Rev Clin Pharmacol. 2014 Nov;7(6):761-77. doi: 10.1586/17512433.2014.966812. Review.

0

0

0

PUBMED

Accurate detection of Parkinson's disease in tremor syndromes using olfactory testing.

Wolz M, Hähner A, Meixner L, Löhle M, Reichmann H, Hummel T, Storch A.

Eur Neurol. 2014;72(1-2):1-6. doi: 10.1159/000358054.

0

0

0

PUBMED

Do genetic factors protect against Parkinson's disease? What I can learn from my healthy grandma.

Dashtipour K.

Med Hypotheses. 2014 Dec;83(6):637-9. doi: 10.1016/j.mehy.2014.09.024.

0

0

0

PUBMED

The value of peer-led support groups among caregivers of persons with Parkinson's disease.

Abendroth M, Greenblum CA, Gray JA.

Holist Nurs Pract. 2014 Jan-Feb;28(1):48-54. doi: 10.1097/HNP.0000000000000004.

0

0

0

PUBMED

Impact of bilateral subthalamic stimulation on motor/cognitive functions in Parkinson's disease.

Asahi T, Nakamichi N, Takaiwa A, Kashiwazaki D, Koh M, Dougu N, Takashima S, Tanaka K, Kuroda S.

Neurol Med Chir (Tokyo). 2014;54(7):529-36.

0

0

0

PUBMED

Real life cost and quality of life associated with continuous intraduodenal levodopa infusion compared with oral treatment in Parkinson patients.

Lundqvist C, Beiske AG, Reiertsen O, Kristiansen IS.

J Neurol. 2014 Dec;261(12):2438-45. doi: 10.1007/s00415-014-7515-4.

0

0

0

PUBMED

Frontal corpus callosum alterations in progressive supranuclear palsy but not in Parkinson's disease.

Rosskopf J, Müller HP, Huppertz HJ, Ludolph AC, Pinkhardt EH, Kassubek J.

Neurodegener Dis. 2014;14(4):184-93. doi: 10.1159/000367693.

0

0

0

PUBMED

Properties of extracellular DNA from the cerebrospinal fluid and blood plasma during Parkinson's disease.

Glebova KV, Konorova IL, Poleshchuk VV, Baidakova GV, Veiko NN.

Bull Exp Biol Med. 2014 Apr;156(6):826-8. doi: 10.1007/s10517-014-2461-9.

0

0

0

PUBMED

G-protein coupled receptor 6 deficiency alters striatal dopamine and cAMP concentrations and reduces dyskinesia in a mouse model of Parkinson's disease.

Oeckl P, Hengerer B, Ferger B.

Exp Neurol. 2014 Jul;257:1-9. doi: 10.1016/j.expneurol.2014.04.010.

0

0

0

PUBMED

The latest evidence on target selection in deep brain stimulation for Parkinson's disease.

Lukins TR, Tisch S, Jonker B.

J Clin Neurosci. 2014 Jan;21(1):22-7. doi: 10.1016/j.jocn.2013.05.011. Review.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy